Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-12-01 Purchase | 2023-12-05 4:30 pm | Generation Bio Co. | GBIO | Quinn Anthony G. Director | 88,495 | $1.41 | $124,778 | 161,332 (Indirect Direct) | View |
| 2022-03-16 Purchase | 2022-03-18 06:46 am | Aeglea BioTherapeutics Inc. | AGLE | Quinn Anthony G. President & CEO | 80,079 | $2.344 | $187,705 | 816,835 (Indirect Direct) | View |
| 2022-03-11 Purchase | 2022-03-15 6:32 pm | Aeglea BioTherapeutics Inc. | AGLE | Quinn Anthony G. President & CEO | 144,666 | $1.942 | $280,943 | 739,756 (Indirect Direct) | View |
| 2021-12-09 Purchase | 2021-12-13 8:39 pm | Aeglea BioTherapeutics Inc. | AGLE | Quinn Anthony G. President & CEO | 53,634 | $3.7098 | $198,972 | 595,090 (Indirect Direct) | View |
| 2020-04-30 Purchase | 2020-05-04 07:30 am | Aeglea BioTherapeutics Inc. | AGLE | Quinn Anthony G. President & CEO | 165,000 | $4.75 | $783,750 | 538,469 (Direct) | View |
| 2019-06-12 Purchase | 2019-06-14 5:22 pm | Aeglea BioTherapeutics Inc. | AGLE | Quinn Anthony G. President & CEO | 31,905 | $6.1574 | $196,453 | 353,643 (Direct) | View |
| 2019-05-20 Purchase | 2019-05-22 4:55 pm | Aeglea BioTherapeutics Inc. | AGLE | Quinn Anthony G. President & CEO | 26,592 | $6.7702 | $180,032 | 321,738 (Direct) | View |
| 2019-02-15 Purchase | 2019-05-17 5:04 pm | Aeglea BioTherapeutics Inc. | AGLE | Quinn Anthony G. President & CEO | 18,713 | $6.7546 | $126,399 | 295,146 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-08 Option Award | 2023-06-12 4:15 pm | N/A 2033-06-07 | Generation Bio Co. | GBIO | Quinn Anthony G. Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 4:05 pm | N/A 2032-06-08 | Generation Bio Co. | GBIO | Quinn Anthony G. Director | 19,200 | $0 | 19,200 (Direct) | View |
| 2022-02-17 Option Award | 2022-02-22 4:57 pm | N/A 2032-02-16 | Aeglea BioTherapeutics Inc. | AGLE | Quinn Anthony G. President & CEO | 350,000 | $0 | 350,000 (Direct) | View |
| 2018-12-28 Ownership | 2022-02-14 5:19 pm | N/A N/A | Aeglea BioTherapeutics Inc. | AGLE | Quinn Anthony G. President & CEO | 266,295 | $0 | 537,640 (Direct) | View |
| 2021-10-28 Gift | 2021-10-29 4:01 pm | N/A N/A | Generation Bio Co. | GBIO | Quinn Anthony G. Director | 72,837 | $0 | 72,837 (Direct) | View |
| 2021-06-30 Option Award | 2021-07-01 4:22 pm | 2022-06-30 2031-06-29 | Kaleido Biosciences Inc. | KLDO | Quinn Anthony G. Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-06-09 Option Award | 2021-06-11 4:08 pm | N/A 2031-06-08 | Generation Bio Co. | GBIO | Quinn Anthony G. Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-02-17 Option Award | 2021-02-19 5:08 pm | N/A 2031-02-16 | Aeglea BioTherapeutics Inc. | AGLE | Quinn Anthony G. President & CEO | 330,000 | $0 | 330,000 (Direct) | View |
| 2020-06-30 Option Award | 2020-07-01 4:16 pm | 2021-06-30 2030-06-30 | Kaleido Biosciences Inc. | KLDO | Quinn Anthony G. Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2020-06-16 Conversion | 2020-06-18 5:31 pm | N/A N/A | Generation Bio Co. | GBIO | Quinn Anthony G. Director | 84,030 | $0 | 72,837 (Direct) | View |
| 2020-06-11 Option Award | 2020-06-15 5:23 pm | N/A 2030-06-10 | Generation Bio Co. | GBIO | Quinn Anthony G. Director | 52,000 | $0 | 52,000 (Direct) | View |
Ownership | 2020-06-11 8:33 pm | N/A N/A | Generation Bio Co. | GBIO | Quinn Anthony G. Director | 0 | $0 | 72,837 (Direct) | View |
| 2020-02-14 Option Award | 2020-02-19 5:13 pm | N/A 2030-02-13 | Aeglea BioTherapeutics Inc. | AGLE | Quinn Anthony G. President & CEO | 301,000 | $0 | 301,000 (Direct) | View |
| 2019-10-04 Exercise | 2019-10-07 4:09 pm | N/A N/A | Aeglea BioTherapeutics Inc. | AGLE | Quinn Anthony G. President & CEO | 17,603 | $6.31 | 491,822 (Direct) | View |
| 2019-10-04 Exercise | 2019-10-07 4:09 pm | N/A 2026-03-17 | Aeglea BioTherapeutics Inc. | AGLE | Quinn Anthony G. President & CEO | 18,265 | $0 | 491,822 (Direct) | View |
| 2019-10-04 Exercise | 2019-10-07 4:09 pm | N/A N/A | Aeglea BioTherapeutics Inc. | AGLE | Quinn Anthony G. President & CEO | 662 | $5.46 | 491,822 (Direct) | View |
| 2019-03-04 Conversion | 2019-03-04 8:13 pm | N/A N/A | Kaleido Biosciences Inc. | KLDO | Quinn Anthony G. Director | 38,560 | $0 | 31,603 (Direct) | View |
| 2019-02-28 Option Award | 2019-03-01 5:08 pm | N/A 2029-02-27 | Aeglea BioTherapeutics Inc. | AGLE | Quinn Anthony G. President & CEO | 280,000 | $0 | 280,000 (Direct) | View |
Ownership | 2019-02-27 6:12 pm | N/A N/A | Kaleido Biosciences Inc. | KLDO | Quinn Anthony G. Director | 0 | $0 | 62,853 (Direct) | View |
| 2019-02-06 Exercise | 2019-02-08 4:15 pm | N/A N/A | Aeglea BioTherapeutics Inc. | AGLE | Quinn Anthony G. President & CEO | 7,433 | $6.31 | 414,612 (Direct) | View |
| 2019-02-06 Exercise | 2019-02-08 4:15 pm | N/A 2026-03-17 | Aeglea BioTherapeutics Inc. | AGLE | Quinn Anthony G. President & CEO | 8,756 | $0 | 414,612 (Direct) | View |
| 2019-02-06 Exercise | 2019-02-08 4:15 pm | N/A N/A | Aeglea BioTherapeutics Inc. | AGLE | Quinn Anthony G. President & CEO | 1,323 | $5.46 | 414,612 (Direct) | View |